+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology, Application, and End User

  • ID: 5557862
  • Report
  • February 2022
  • Region: Global
  • 239 Pages
  • The Insight Partners

FEATURED COMPANIES

  • Abbott
  • Admera Health
  • Dynamic DNA Laboratories
  • F. Hoffmann-la Roche Ltd
  • Illumina, Inc.
  • Myriad Genetics, Inc.
The pharmacogenomics market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is estimated to grow at a CAGR of 10.3% from 2021 to 2028. Several factors such as the increasing prevalence of chronic diseases, rising demand for precision medicine, and the growing funding for pharmacogenomic research activities boost the market growth. However, the lack of skilled professionals hampers the market growth.



Pharmacogenomics (Pharmacogenetics) is the study of the role of genes in manipulating the activity of drugs, which assists the researchers in predicting the drug response to develop personalized medicines. It involves proactive testing of single or multiple genes to improve the therapeutic response of treatments and reduce the severity of adverse events. Pharmacogenomic technologies also have the potential to reduce the overall cost of the treatment.

Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is further segmented into standard PCR, real-time PCR, and digital PCR. The PCR segment held the largest share of 37.71% of the pharmacogenomics market in 2021. Based on application, the pharmacogenomics market is segmented into drug discovery, oncology, neurology and psychiatry, pain management, cardiovascular diseases, and others. The oncology segment accounted for the largest market share in 2021, whereas the drug discovery segment is expected to register the highest CAGR in the market during the forecast period.

Based on end user, the pharmacogenomics market has been segmented into hospitals and clinics, biopharmaceutical companies, CROs and CDMOs, and others. The CROs and CDMOs segment accounted for the largest market share in 2021. However, the hospitals and clinics segment is expected to register the highest CAGR in the market during the forecast period.

National Centre of Excellence in Genomic Medicine Research, World Health Organization, Indian Council of Medical Research, and National Center for Health Statistics are among the primary and secondary sources referred to while preparing the pharmacogenomics market report.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the pharmacogenomics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global Intradermal Injection market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distributions.
Frequently Asked Questions about the Global Pharmacogenomics Market

What is the estimated value of the Global Pharmacogenomics Market?

The Global Pharmacogenomics Market was estimated to be valued at $7087.8 million in 2021.

What is the growth rate of the Global Pharmacogenomics Market?

The growth rate of the Global Pharmacogenomics Market is 10.3%, with an estimated value of $14107.8 million by 2028.

What is the forecasted size of the Global Pharmacogenomics Market?

The Global Pharmacogenomics Market is estimated to be worth $14107.8 million by 2028.

Who are the key companies in the Global Pharmacogenomics Market?

Key companies in the Global Pharmacogenomics Market include F. Hoffmann, la Roche Ltd, Abbott, Oxford Nanopore Technologies, Thermo Fisher Scientific Inc., Illumina, Inc., QIAGEN, Agilent Technologies, Inc. and Admera Health.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Admera Health
  • Dynamic DNA Laboratories
  • F. Hoffmann-la Roche Ltd
  • Illumina, Inc.
  • Myriad Genetics, Inc.

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Pharmacogenomics Market - By Technology
1.3.2 Global Pharmacogenomics Market - By Application
1.3.3 Global Pharmacogenomics Market - By End User
1.3.4 Global Pharmacogenomics Market - By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Pharmacogenomics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East And Africa PEST Analysis
4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion
5. Pharmacogenomics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Growing Funding for Pharmacogenomics
5.2 Market Restraints
5.2.1 Lack of Skilled Professionals
5.3 Market Opportunities
5.3.1 Increasing Demand for Third Generation Sequencing
5.4 Future Trends
5.4.1 Increasing Demand for Personalized Medicines
6. Pharmacogenomics Market - Global Analysis
6.1 Global Pharmacogenomics Market Revenue Forecast and Analysis
6.2 Global Pharmacogenomics Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Pharmacogenomics Market Revenue and Forecasts To 2028 - Technology
7.1 Overview
7.2 Global Pharmacogenomics Market Share by Technology - 2021 & 2028 (%)
7.3 Polymerase Chain Reaction
7.3.1 Overview
7.3.2 Polymerase Chain Reaction: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)
7.3.3 Real Time PCR
7.3.3.1 Overview
7.3.3.2 Real Time PCR: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)
7.3.4 Standard PCR
7.3.4.1 Overview
7.3.4.2 Standard PCR: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)
7.3.5 Digital PCR
7.3.5.1 Overview
7.3.5.2 Digital PCR: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)
7.4 Sequencing
7.4.1 Overview
7.4.2 Sequencing: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)
7.5 Microarray
7.5.1 Overview
7.5.2 Microarray: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)
7.6 Gel Electrophoresis
7.6.1 Overview
7.6.2 Gel Electrophoresis: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)
7.7 Mass Spectrometry
7.7.1 Overview
7.7.2 Mass Spectrometry: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)
8. Global Pharmacogenomics Market Revenue and Forecasts To 2028- by Application
8.1 Overview
8.2 Global Pharmacogenomics Market Share by Application - 2021 & 2028 (%)
8.3 Drug Discovery
8.3.1 Overview
8.3.2 Drug Discovery: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Oncology
8.4.1 Overview
8.4.2 Oncology: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)
8.5 Neurology & Psychiatry
8.5.1 Overview
8.5.2 Neurology & Psychiatry: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)
8.6 Pain Management
8.6.1 Overview
8.6.2 Pain Management: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)
8.7 Cardiovascular Disease
8.7.1 Overview
8.7.2 Cardiovascular Disease: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)
9. Pharmacogenomics Market Revenue and Forecasts To 2028 - End User
9.1 Overview
9.2 Global Pharmacogenomics Market Share by End User - 2021 & 2028 (%)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Biopharmaceutical Companies
9.4.1 Overview
9.4.2 Biopharmaceuticals Companies: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)
9.5 CROs and CDMOs
9.5.1 Overview
9.5.2 CROs and CDMOs: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)
10. Pharmacogenomics Market Revenue and Forecasts to 2028 - Geographical Analysis
10.1 North America: Pharmacogenomics Market
10.1.1 Overview
10.1.2 North America: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Pharmacogenomics Market, by Technology, 2019-2028 (US$ Million)
10.1.3.1 North America: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.1.4 North America: Pharmacogenomics Market, by Application, 2019-2028 (US$ Million)
10.1.5 North America: Pharmacogenomics Market, by End-User, 2019-2028 (US$ Million)
10.1.6 North America: Pharmacogenomics Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.3 US: Pharmacogenomics Market, by Technology, 2019-2028 (US$ Million)
10.1.6.1.3.1 US: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.1.6.1.4 US: Pharmacogenomics Market, by Application, 2019-2028 (US$ Million)
10.1.6.1.5 US: Pharmacogenomics Market, by End-User, 2019-2028 (US$ Million)
10.1.6.2 Canada: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.3 Canada: Pharmacogenomics Market, by Technology, 2019-2028 (US$ Million)
10.1.6.2.3.1 Canada: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.1.6.2.4 Canada: Pharmacogenomics Market, by Application, 2019-2028 (US$ Million)
10.1.6.2.5 Canada: Pharmacogenomics Market, by End-User, 2019-2028 (US$ Million)
10.1.6.3 Mexico: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.3 Mexico: Pharmacogenomics Market, by Technology, 2019-2028 (US$ Million)
10.1.6.3.3.1 Mexico: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.1.6.3.4 Mexico: Pharmacogenomics Market, by Application, 2019-2028 (US$ Million)
10.1.6.3.5 Mexico: Pharmacogenomics Market, by End-User, 2019-2028 (US$ Million)
10.2 Europe: Pharmacogenomics Market
10.2.1 Overview
10.2.2 Europe: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Pharmacogenomics Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
10.2.3.1 Europe: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.2.4 Europe: Pharmacogenomics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.2.5 Europe: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
10.2.6 Europe: Pharmacogenomics Market, by Country, 2021 & 2028 (%)
10.2.6.1 Germany: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Overview
10.2.6.1.2 Germany: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3 Germany: Pharmacogenomics Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3.1 Germany: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.2.6.1.4 Germany: Pharmacogenomics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.5 Germany: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2 France: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 Overview
10.2.6.2.2 France: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3 France: Pharmacogenomics Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3.1 France: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.2.6.2.4 France: Pharmacogenomics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.5 France: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3 UK: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.1 Overview
10.2.6.3.2 UK: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.3 UK: Pharmacogenomics Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.3.1 UK: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.2.6.3.4 UK: Pharmacogenomics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.5 UK: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4 Italy: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.1 Overview
10.2.6.4.2 Italy: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.3 Italy: Pharmacogenomics Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.3.1 Italy: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.2.6.4.4 Italy: Pharmacogenomics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.5 Italy: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5 Spain: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.1 Overview
10.2.6.5.2 Spain: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.3 Spain: Pharmacogenomics Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.3.1 Spain: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.2.6.5.4 Spain: Pharmacogenomics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.5 Spain: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6 Rest of Europe: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.3 Rest of Europe: Pharmacogenomics Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.3.1 Rest of Europe: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.2.6.6.4 Rest of Europe: Pharmacogenomics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.5 Rest of Europe: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
10.3 Asia Pacific Pharmacogenomics Market Revenue and Forecasts To 2028
10.3.1 Overview
10.3.2 Asia Pacific Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.3.3 Asia Pacific: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
10.3.3.1 Asia Pacific: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.3.4 Asia Pacific: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.3.5 Asia Pacific: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
10.3.6 Asia Pacific: Pharmacogenomics Market Revenue and Forecasts to 2028, By Country (%)
10.3.6.1 Japan: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.1.1 Overview
10.3.6.1.2 Japan: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.1.3 Japan: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
10.3.6.1.3.1 Japan: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.3.6.1.4 Japan: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.3.6.1.5 Japan: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
10.3.6.2 China: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.2.1 Overview
10.3.6.2.2 China: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.2.3 China: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
10.3.6.2.3.1 China: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.3.6.2.4 China: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.3.6.2.5 China: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
10.3.6.3 India Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.3.3 India: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
10.3.6.3.3.1 India: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.3.6.3.4 India: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.3.6.3.5 India: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
10.3.6.4 South Korea: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.4.1 Overview
10.3.6.4.2 South Korea: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.4.3 South Korea: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
10.3.6.4.3.1 South Korea: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.3.6.4.4 South Korea: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.3.6.4.5 South Korea: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
10.3.6.5 Australia: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.5.1 Overview
10.3.6.5.2 Australia: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.5.3 Australia: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
10.3.6.5.3.1 Australia: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.3.6.5.4 Australia: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.3.6.5.5 Australia: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
10.3.6.6 Rest of Asia Pacific: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
10.3.6.6.3.1 Rest of Asia Pacific: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million) 131
10.3.6.6.4 Rest of Asia Pacific: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
10.4 Middle East & Africa Pharmacogenomics Market Revenue and Forecasts To 2028
10.4.1 Overview
10.4.2 Middle East & Africa Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.4.3 Middle East & Africa: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
10.4.3.1 Middle East & Africa: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.4.4 Middle East & Africa: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.4.5 Middle East & Africa: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
10.4.6 Middle East & Africa Pharmacogenomics Market Revenue and Forecasts to 2028, By Country (%)
10.4.6.1 UAE: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.1.1 Overview
10.4.6.1.2 UAE: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.1.3 UAE: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
10.4.6.1.3.1 UAE: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.4.6.1.4 UAE: Pharmacogenomics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.4.6.1.5 UAE: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
10.4.6.2 Saudi Arabia: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.2.1 Overview
10.4.6.2.2 Saudi Arabia: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.2.3 Saudi Arabia: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
10.4.6.2.3.1 Saudi Arabia: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.4.6.2.4 Saudi Arabia: Pharmacogenomics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.4.6.2.5 Saudi Arabia: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
10.4.6.3 South Africa: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.3.1 Overview
10.4.6.3.2 South Africa Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.3.3 South Africa: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
10.4.6.3.3.1 South Africa: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.4.6.3.4 South Africa: Pharmacogenomics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.4.6.3.5 South Africa: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
10.4.6.4 Rest of Middle East and Africa: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.4.1 Overview
10.4.6.4.2 Rest of Middle East and Africa: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.4.3 Rest of Middle East & Africa: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
10.4.6.4.3.1 Rest of Middle East & Africa: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.4.6.4.4 Rest of Middle East & Africa: Pharmacogenomics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.4.6.4.5 Rest of Middle East and Africa: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
10.5 South And Central America Pharmacogenomics Market Revenue and Forecasts To 2028
10.5.1 Overview
10.5.2 South and Central America Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.5.3 South and Central America Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
10.5.3.1 South and Central America: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.5.4 South and Central America: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.5.5 South and Central America: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
10.5.6 South and Central America Pharmacogenomics Market Revenue and Forecasts to 2028, By Country (%)
10.5.6.1 Argentina Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.5.6.1.1 Overview
10.5.6.1.2 Argentina Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.5.6.1.3 Argentina: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
10.5.6.1.3.1 Argentina: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.5.6.1.4 Argentina: Pharmacogenomics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.5.6.1.5 Argentina: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
10.5.6.2 Brazil: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.5.6.2.1 Overview
10.5.6.2.2 Brazil: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
10.5.6.2.3 Brazil: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
10.5.6.2.3.1 Brazil: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.5.6.2.4 Brazil: Pharmacogenomics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.5.6.2.5 Brazil: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
10.5.6.3 Rest of South and Central America: Pharmacogenomics Market - Revenue and Forecast to 2028 (USD Mn)
10.5.6.3.1 Overview
10.5.6.3.2 Rest of South and Central America: Pharmacogenomics Market - Revenue and Forecast to 2028 (USD Mn)
10.5.6.3.3 Rest of South & Central America: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
10.5.6.3.3.1 Rest of South & Central America: Pharmacogenomics Market, by PCR, 2019-2028 (US$ Million)
10.5.6.3.4 Rest of South & Central America: Pharmacogenomics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.5.6.3.5 Rest of South and Central America: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
11. Impact of COVID-19 Pandemic on Global Pharmacogenomics Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Pharmacogenomics Market
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Abbott
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 F. HOFFMANN-LA ROCHE LTD.
13.2.1 Key Facts 176
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Oxford Nanopore Technologies
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 THERMO FISHER SCIENTIFIC INC.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Illumina, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 QIAGEN
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Agilent Technologies, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Myriad Genetics, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Admera Health
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Dynamic DNA Laboratories
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Publisher 205
14.2 Glossary of Terms
List of Tables
Table 1. North America Pharmacogenomics Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 2. North America: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Pharmacogenomics Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 4. US Pharmacogenomics Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 5. US Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 6. US Pharmacogenomics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 7. US Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada: Pharmacogenomics Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Pharmacogenomics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico: Pharmacogenomics Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Pharmacogenomics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 16. Europe: Pharmacogenomics Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 17. Europe: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 18. Europe: Pharmacogenomics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 19. Europe: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 20. Germany: Pharmacogenomics Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 21. Germany: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 22. Germany: Pharmacogenomics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 23. Germany: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 24. France: Pharmacogenomics Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 25. France: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 26. France: Pharmacogenomics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 27. France: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 28. UK: Pharmacogenomics Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 29. UK: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 30. UK: Pharmacogenomics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 31. UK: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 32. Italy: Pharmacogenomics Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 33. Italy: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 34. Italy: Pharmacogenomics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 35. Italy: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 36. Spain: Pharmacogenomics Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 37. Spain: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 38. Spain: Pharmacogenomics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 39. Spain: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 40. Rest of Europe: Pharmacogenomics Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 41. Rest of Europe: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe: Pharmacogenomics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 43. Rest of Europe: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 44. Asia Pacific: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million).
Table 45. Asia Pacific: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 46. Asia Pacific: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 47. Asia Pacific: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 48. Japan: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 49. Japan: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 50. Japan: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 51. Japan: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 52. China: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 53. China: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 54. China: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 55. China: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 56. India: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 57. India: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 58. India: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 59. India: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 60. South Korea: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 61. South Korea: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 62. South Korea: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 63. South Korea: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 64. Australia: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 65. Australia: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 66. Australia: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 67. Australia: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 68. Rest of Asia Pacific: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 69. Rest of Asia Pacific: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 70. Rest of Asia Pacific: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 71. Rest of Asia Pacific: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 72. Middle East & Africa: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 73. Middle East & Africa: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 74. Middle East & Africa: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 75. Middle East & Africa: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 76. UAE: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 77. UAE: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 78. UAE: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 79. UAE: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 80. Saudi Arabia: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 81. Saudi Arabia: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 82. Saudi Arabia: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 83. Saudi Arabia: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 84. South Africa Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 85. South Africa: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 86. South Africa: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 87. South Africa: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 88. Rest of Middle East & Africa: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 89. Rest of Middle East & Africa: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 90. Rest of Middle East & Africa: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 91. Rest of Middle East and Africa: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 92. South and Central America Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 93. South and Central America: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 94. South and Central America: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 95. South and Central America: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 96. Argentina: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 97. Argentina: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 98. Argentina: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 99. Argentina: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 100. Brazil: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 101. Brazil: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 102. Brazil: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 103. Brazil: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 104. Rest of South & Central America: Pharmacogenomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 105. Rest of South & Central America: Pharmacogenomics Market, by PCR - Revenue and Forecast to 2028 (US$ Million)
Table 106. Rest of South & Central America: Pharmacogenomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 107. Rest of South and Central America: Pharmacogenomics Market, by End-User - Revenue and Forecast to 2028 (US$ Million)
Table 108. Organic Developments Done By Companies
Table 109. Inorganic Developments Done By Companies
Table 110. Glossary of Terms
List of Figures
Figure 1. Pharmacogenomics Market Segmentation
Figure 2. Pharmacogenomics Market, By Region
Figure 3. Global Pharmacogenomics Market Overview
Figure 4. PCR Segment Held Largest Share of Technology Segment in Pharmacogenomics Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Pharmacogenomics Market, by Geography (US$ Million)
Figure 7. Global Pharmacogenomics Market- Leading Country Markets (US$ Million)
Figure 8. Global Pharmacogenomics Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East And Africa: PEST Analysis
Figure 13. South And Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Global Pharmacogenomics Market - Revenue Forecast and Analysis - 2021 - 2028
Figure 16. Global Pharmacogenomics Market - By Geography Forecast and Analysis - 2021 - 2028
Figure 17. Market Positioning of Key Players in Global Pharmacogenomics Market
Figure 18. Global Pharmacogenomics Market Share by Segment - 2021 & 2028 (%)
Figure 19. Polymerase Chain Reaction: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 20. Real Time PCR: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 21. Standard PCR: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 22. Digital PCR: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 23. Sequencing: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 24. Microarray: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25. Gel Electrophoresis: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26. Mass Spectrometry: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 27. Others: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 28. Global Pharmacogenomics Market Share by Application- 2021 & 2028 (%)
Figure 29. Drug Discovery: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 30. Oncology: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. Neurology & Psychiatry: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32. Pain Management: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 33. Cardiovascular Disease: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34. Others: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 35. Global Pharmacogenomics Market Share by End User - 2021 & 2028 (%)
Figure 36. Hospital and Clinics: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 37. Biopharmaceutical Companies: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 38. CROs and CDMOs: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 39. Others: Pharmacogenomics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 40. North America: Pharmacogenomics Market, by Key Country - Revenue (2021) (US$ Million)
Figure 41. North America Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)
Figure 42. North America: Pharmacogenomics Market, by Country, 2021 & 2028 (%)
Figure 43. US: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 44. Canada: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 45. Mexico: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 46. Europe: Pharmacogenomics Market, by Key Country - Revenue (2021) (US$ Million)
Figure 47. Europe: Pharmacogenomics Market Revenue and Forecast to 2028 (US$ Million)
Figure 48. Europe: Pharmacogenomics Market, by Country, 2021 & 2028 (%)
Figure 49. Germany: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 50. France: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 51. UK: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 52. Italy: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 53. Spain: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 54. Rest of Europe: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 55. Asia Pacific Pharmacogenomics Market Overview, by Country (2021)
Figure 56. Asia Pacific: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 57. Asia Pacific: Pharmacogenomics Market Revenue and Forecasts to 2028, By Country (%)
Figure 58. Japan: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 59. China: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 60. India: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 61. South Korea: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 62. Australia: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 63. Rest of Asia Pacific: Pharmacogenomics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 64. Middle East & Africa Pharmacogenomics Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 65. Middle East & Africa Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 66. Middle East & Africa Pharmacogenomics Market Revenue and Forecasts to 2028, By Country (%)
Figure 67. UAE: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 68. Saudi Arabia: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 69. South Africa: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 70. Rest of Middle East and Africa: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 71. South and Central America Pharmacogenomics Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 72. South and Central America Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 73. South and Central America Pharmacogenomics Market Revenue and Forecasts to 2028, By Country (%)
Figure 74. Argentina Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 75. Brazil: Pharmacogenomics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 76. Rest of South and Central America: Pharmacogenomics Market - Revenue and Forecast to 2028 (USD Mn)
Figure 77. Impact of COVID-19 Pandemic in North America Country Markets
Figure 78. Impact of COVID-19 Pandemic on Sequencing Reagents Market in European Countries
Figure 79. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 80. Impact of COVID-19 Pandemic on Sequencing Reagents Market in Rest of the World
Figure 81. Impact of COVID-19 Pandemic in South and Central America Country Markets
Figure 82. Growth Strategies in the Pharmacogenomics Market
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • F. Hoffmann-la Roche Ltd
  • Abbott
  • Oxford Nanopore Technologies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • QIAGEN
  • Agilent Technologies, Inc.
  • Myriad Genetics, Inc.
  • Admera Health
  • Dynamic DNA Laboratories
Note: Product cover images may vary from those shown